Cite

HARVARD Citation

    Fowler, N. et al. (n.d.). Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study. Hematological oncology. pp. 210-211. [Online]. 
  
Back to record